Stocks
ResMed (RMD) Debt/EBITDA US GAAP (year values) |
|||||||||
| 2022 | 2023 | 2023 | 2024 | 2024 | LTM ? | CAGR 5 years ? | |||
| Debt/EBITDA | 0.54 | 1.01 | 1.01 | 0.38 | 0.40 | 0.37 | |||
| Changes by years, y/y, % | +87% | 0% | -63% | +6% | -21.5% | ||||
ResMed. Debt/EBITDA
ResMed. Debt/EBITDA, changes, %
ResMed (RMD) Debt/EBITDA US GAAP (quarter values) |
||||||||
| 2024Q2 | 2024Q3 | 2024Q3 | 2024Q4 | 2024Q4 | LTM ? | |||
| Debt/EBITDA | 0.83 | 0.64 | 0.62 | 0.39 | 0.39 | 0.37 | ||
| Changes by years, y/y, % | -39% | -44% | -46% | -61% | -61% | |||
| Changes by quarters, q/q, % | -13% | -23% | -4% | -37% | +1% | |||
